{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:05:15Z","timestamp":1781906715276,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.06.072","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T08:08:18Z","timestamp":1562659698000},"page":"7052-7060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Purification of rabies virus produced in Vero cells grown in serum free medium"],"prefix":"10.1016","volume":"37","author":[{"given":"Khaled","family":"Trabelsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Ben Zakour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9la","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.072_b0005","first-page":"263","article-title":"The rabies virus genome: an overview","volume":"60","author":"Tordo","year":"1993","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2019.06.072_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virusres.2006.05.010","article-title":"Molecular characterization of rabies virus isolates in China during 2004","volume":"121","author":"Zhang","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.06.072_b0015","article-title":"The WHO position on rabies immunization \u2013 2018 updates","author":"O'Brien","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.072_b0020","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018\u2013Recommendations","volume":"36","author":"Organization","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.072_b0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.enzmictec.2004.11.008","article-title":"Comparison of various culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor","volume":"36","author":"Trabelsi","year":"2005","journal-title":"Enzyme Microb Technol"},{"key":"10.1016\/j.vaccine.2019.06.072_b0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jbiotec.2005.07.018","article-title":"Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor","volume":"121","author":"Trabelsi","year":"2006","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.072_b0035","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.vaccine.2007.01.086","article-title":"A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions","volume":"25","author":"Rourou","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.072_b0040","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.06.072_b0045","doi-asserted-by":"crossref","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. nature. 1970;227:680. <https:\/\/doi:10.1038\/227680a0>.","DOI":"10.1038\/227680a0"},{"key":"10.1016\/j.vaccine.2019.06.072_b0050","unstructured":"Meslin F. Laboratory techniques in rabies [Eds FX Mes-lin, MM Kaplan, H. Koprowski].\u2014. Geneva: WHO; 1996."},{"issue":"A(1)","key":"10.1016\/j.vaccine.2019.06.072_b0055","first-page":"85","article-title":"Glycosylation and isoelectric properties of complete and defective rabies viruses","volume":"130","author":"Atanasiu","year":"1979","journal-title":"Ann Microbiol"},{"key":"10.1016\/j.vaccine.2019.06.072_b0060","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/erv.11.140","article-title":"From brain passage to cell adaptation: the road of human rabies vaccine development","volume":"10","author":"Wu","year":"2011","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.06.072_b0065","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.vaccine.2014.02.022","article-title":"Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods","volume":"32","author":"Thomassen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.072_b0070","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1016\/j.vaccine.2013.10.043","article-title":"A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab\u00ae when administered according to a post-exposure regimen in healthy children and adults in China","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2019.06.072_b0075","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/j.vaccine.2015.04.050","article-title":"Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium","volume":"33","author":"Mattos","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.072_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1389-1723(02)80212-2","article-title":"Process standardization for optimal virus recovery and removal of substrate DNA and bovine serum proteins in Vero cell-derived rabies vaccine","volume":"94","author":"Kumar","year":"2002","journal-title":"J Biosci Bioeng"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.072_b0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/14760584.2017.1294068","article-title":"Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd","volume":"16","author":"Kulkarni","year":"2017","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.06.072_b0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/978-1-4020-5476-1_114","article-title":"Purification of rabies virus produced on vero cells using chromatography techniques","author":"Chtioui","year":"2007","journal-title":"Cell Technol Cell Prod Springer"},{"issue":"24","key":"10.1016\/j.vaccine.2019.06.072_b0095","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.vaccine.2014.02.036","article-title":"Development of a membrane adsorber based capture step for the purification of yellow fever virus","volume":"32","author":"Pato","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.072_b0100","unstructured":"GE Healthcare Life Sciences. Application note 29-0003-34 AA. Purification of influenza A\/H1N1 using Capto Core 700"},{"key":"10.1016\/j.vaccine.2019.06.072_b0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/hum.2005.16.393","article-title":"Havenga M, Marzio G. Quantification of residual host cell DNA in adenoviral vectors produced on PER. C6\u00ae cells","volume":"16","author":"Gijsbers","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2019.06.072_b0110","doi-asserted-by":"crossref","unstructured":"Kumar AAP, Mani KR, Palaniappan C, Bhau LNR, Swaminathan K. Purification, potency and immunogenicity analysis of Vero cell culture-derived rabies vaccine: a comparative study of single-step column chromatography and zonal centrifuge purification. Microbes and infection, 2005. 7;(9-10):1110-1116.https:\/\/doi.org\/10.1016\/j.micinf.2005.03.034","DOI":"10.1016\/j.micinf.2005.03.034"},{"key":"10.1016\/j.vaccine.2019.06.072_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jviromet.2016.02.011","article-title":"Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli","volume":"232","author":"Lagoutte","year":"2016","journal-title":"J Virol Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.072_b0120","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4161\/hv.20985","article-title":"Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology","volume":"8","author":"Yu","year":"2012","journal-title":"Human Vacc Immunotherapeut."},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.072_b0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biologicals.2014.06.005","article-title":"Removing residual DNA from Vero-cell culture-derived human rabies vaccine by using nuclease","volume":"42","author":"Li","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.06.072_b0130","article-title":"New human rabies vaccines in the pipeline","author":"Fooks","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.072_b0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biologicals.2012.12.001","article-title":"Size analysis of residual host cell DNA in cell culture-produced vaccines by capillary gel electrophoresis","volume":"41","author":"Shen","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.06.072_b0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biologicals.2009.02.015","article-title":"Issues associated with residual cell-substrate DNA in viral vaccines","volume":"37","author":"Sheng-Fowler","year":"2009","journal-title":"Biologicals."},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.072_b0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.virol.2012.09.019","article-title":"Monolithic ion exchange chromatographic methods for virus purification","volume":"434","author":"Oksanen","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.06.072_b0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1743-422X-11-99","article-title":"Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column","volume":"11","author":"Venkatachalam","year":"2014","journal-title":"Virology J"},{"key":"10.1016\/j.vaccine.2019.06.072_b0155","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.vaccine.2014.02.086","article-title":"Purification of Vero cell derived live replication deficient influenza A and B virus by ion exchange monolith chromatography","volume":"32","author":"Banjac","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:04Z","timestamp":1759401364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19308497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":31,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X19308497"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purification of rabies virus produced in Vero cells grown in serum free medium","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}